Stockholm, Sweden

Luis A Parodi

This inventor holds 20 USPTO granted patents and 1 published patent application. Top assignees: Pharmacia & Upjohn Company, Elan Pharmaceuticals, Inc., Other. Active years: 2002-2010.

USPTO Granted Patents = 20 

% Patents Active = 55.0

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 257(Granted Patents)


Location History:

  • Stockkholm, SE (2004)
  • Stockholm, SE (2002 - 2010)

Company Filing History:


Years Active: 2002-2010

Loading Chart...
20 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Luis A Parodi:

Title: Inventor Spotlight: Luis A Parodi

Introduction:

Luis A Parodi is a prolific inventor based in Stockholm, SE, known for his groundbreaking work in the field of Alzheimer's disease research. With an impressive portfolio of 20 patents, he has made significant contributions to the scientific community through his innovative enzyme and enzymatic procedures.

Latest Patents:

Parodi's latest patents focus on Alzheimer's disease secretase, providing crucial insights into cleaving the β-secretase cleavage site of the APP protein. These patents offer valuable advancements in identifying candidate therapeutics for the treatment and prevention of Alzheimer's disease.

Career Highlights:

Throughout his career, Luis A Parodi has made significant strides in the field of biotechnology. Notably, he has worked with esteemed companies such as Pharmacia & Upjohn Company, where his innovative work has left a lasting impact on the industry.

Collaborations:

Parodi has collaborated with esteemed professionals in the field, including coworkers such as Mark E Gurney and Robert L Heinrikson. These collaborations have helped further his research and bring his inventions to the forefront of scientific advancement.

Conclusion:

In conclusion, Luis A Parodi stands as a beacon of innovation in the field of Alzheimer's disease research. His dedication to advancing enzymatic procedures and identifying novel therapeutics underscores his commitment to making a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…